Transition Day In The US: 96 Drugs Make The Move To Biologics Regulation

 
• By Sue Sutter
  
Open wooden door to the new world with green environment. Climate change concept.
US FDA’s door is now open to applications for biosimilar and interchangeable insulins. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics